logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

AACR 2018 — CREATE data support crizotinib as SoC for ALK+ myofibroblastic tumor

ALK+ IMFTs demonstrate significant response to ALK inhibitor crizotinib